About multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors

Blood. 2008 Jul 1;112(1):208-9; author reply 209-10. doi: 10.1182/blood-2008-04-150813.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD34 / blood*
  • Encephalomyelitis, Autoimmune, Experimental / blood
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / immunology
  • Humans
  • Mice
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / drug therapy*
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD34
  • Natalizumab